tiprankstipranks
Trending News
More News >
Altria Group Inc (MO)
NYSE:MO
US Market

Altria Group (MO) Earnings Dates, Call Summary & Reports

Compare
18,640 Followers

Earnings Data

Report Date
Apr 30, 2026
Before Open (Confirmed)
Period Ending
2026 (Q1)
Consensus EPS Forecast
1.24
Last Year’s EPS
1.23
Same Quarter Last Year
Moderate Buy
Based on 7 Analysts Ratings

Earnings Call Summary

Q4 2025
Earnings Call Date:Jan 29, 2026|
% Change Since:
|
Earnings Call Sentiment|Neutral
The call conveyed a mix of positive strategic and financial developments alongside material near‑term challenges. Positives include full‑year EPS growth (4.4%), strong full‑year smokeable margins and net price realization, substantial shareholder returns (~$8B), progress in the nicotine pouch portfolio (ON and ON PLUS FDA authorizations and a planned national rollout), international expansion, and a clear plan to unlock import/export duty‑drawback benefits (with management citing <1 year payback). Offsetting these are meaningful cigarette volume declines (~9–10% FY adjusted), Q4 margin and adjusted OCI pressures in certain segments, intense competitive/promotional activity in nicotine pouches, a large $1.3B noncash e‑vapor impairment, and the ongoing industry headwind from illicit disposable e‑vapor products. Overall, the positives and negatives are roughly balanced — the company shows solid cash generation, strategic progress and guidance for modest EPS growth in 2026, but also faces significant operational and market headwinds that temper near‑term outlook.
Company Guidance
Altria guided 2026 adjusted diluted EPS of $5.56 to $5.72 (a 2.5%–5.5% increase from the $5.42 2025 base), with growth weighted to the second half of the year as cigarette import/export activity ramps; the outlook contemplates planned investments (including contract manufacturing capabilities, marketplace support, smoke‑free product support, and R&D), expects Helix to be profitable for full‑year 2026, assumes limited near‑term impact on combustible and e‑vapor volumes from illicit‑market enforcement, and factors in that NJOY ACE will not return to the marketplace in 2026; management also discussed elevated 2026 capital spending centered on import/export and smoke‑free capabilities in the roughly $300–$375 million range.
Adjusted EPS Growth and 2026 Guidance
Full-year 2025 adjusted diluted EPS grew 4.4% to a $5.42 base. Management guided 2026 adjusted diluted EPS of $5.56 to $5.72, implying growth of approximately 2.5% to 5.5%, with growth expected to be weighted to the second half of the year.
Significant Shareholder Returns
Returned ~$8.0 billion to shareholders in 2025 (dividends plus share repurchases). Paid $7.0 billion in dividends, raised the dividend by 3.9% (sixtieth increase in 56 years), repurchased >17 million shares for ~$1.0 billion, with ~$1.0 billion remaining under the $2.0 billion repurchase program.
Strong Full-Year Smokeable Profitability
Smokeable products delivered over $11 billion in adjusted OCI for the full year with adjusted OCI margins expanding 1.8 percentage points to 63.4%. Full-year net price realization was robust at 8.4%.
Nicotine Pouch Growth and ON / ON PLUS Progress
Helix delivered ON full-year reported shipments of more than 177 million cans (≈+11% year over year) and Q4 reported shipments of >44 million cans. ON retail share was 7.7% in Q4 and 8.2% for the full year. FDA granted marketing orders for ON PLUS Mint, Wintergreen, and Tobacco (6 mg and 9 mg); shipments resumed in FL, NC and TX and a national rollout is planned in H1 2026. Management expects Helix to remain profitable in 2026.
International Modern Oral Expansion
Expanded international footprint for Fumi and ON PLUS across e-commerce and targeted retail: Fumi reached ~40,000 retail locations in seven markets and added three line extensions (12 unique flavors total), producing encouraging early performance and consumer insights for future product development.
Industry Smoke-Free Momentum & Regulatory Steps
Total nicotine industry equivalized volumes increased for the third consecutive year and are estimated to have grown ~2% CAGR over the past five years. Smoke-free alternatives are estimated to represent >50% of the total nicotine space (up 5 percentage points from prior year). E-vapor category grew ~30% in 2025. Regulatory progress includes legislation requiring the FDA to allocate at least $200 million of tobacco user fees to enforcement activities and early signs tariffs/enforcement beginning to moderate illicit supply.
Balance Sheet Strength and ABI Income
Total debt to EBITDA was ~2.0x at year-end (in line with target). ABI adjusted equity earnings were $161 million in Q4 (up ~1.3% year over year).
Import/Export Investment with Rapid Payback Potential
Planned CapEx for 2026 elevated to support import-export (duty drawback) and contract manufacturing capabilities (guidance range mentioned $300M–$375M). Management indicated the return on import-export investments is strong with payback under one year and the investments support long-term manufacturing flexibility.

Altria Group (MO) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

MO Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Apr 30, 2026
2026 (Q1)
1.24 / -
1.23
Jan 29, 2026
2025 (Q4)
1.32 / 1.30
1.290.78% (+0.01)
Oct 30, 2025
2025 (Q3)
1.44 / 1.45
1.385.07% (+0.07)
Jul 30, 2025
2025 (Q2)
1.39 / 1.44
1.319.92% (+0.13)
Apr 29, 2025
2025 (Q1)
1.19 / 1.23
1.156.96% (+0.08)
Jan 30, 2025
2024 (Q4)
1.28 / 1.29
1.189.32% (+0.11)
Oct 31, 2024
2024 (Q3)
1.35 / 1.38
1.287.81% (+0.10)
Jul 31, 2024
2024 (Q2)
1.34 / 1.31
1.310.00% (0.00)
Apr 25, 2024
2024 (Q1)
1.15 / 1.15
1.18-2.54% (-0.03)
Feb 01, 2024
2023 (Q4)
1.18 / 1.18
1.180.00% (0.00)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

MO Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Jan 29, 2026
$63.13$59.76-5.34%
Oct 30, 2025
$60.86$56.10-7.82%
Jul 30, 2025
$57.37$59.43+3.59%
Apr 29, 2025
$55.28$55.83+0.99%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Altria Group Inc (MO) report earnings?
Altria Group Inc (MO) is schdueled to report earning on Apr 30, 2026, Before Open (Confirmed).
    What is Altria Group Inc (MO) earnings time?
    Altria Group Inc (MO) earnings time is at Apr 30, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is MO EPS forecast?
          MO EPS forecast for the fiscal quarter 2026 (Q1) is 1.24.

            Altria Group (MO) Earnings News

            MO Earnings: Q2 Beats Boost Altria Stock Today
            Premium
            Market News
            MO Earnings: Q2 Beats Boost Altria Stock Today
            6M ago
            MO Earnings: Altria Drops As Q2 Results Miss Estimates
            Premium
            Market News
            MO Earnings: Altria Drops As Q2 Results Miss Estimates
            2y ago
            Altria (NYSE:MO) Gains after Reporting Quarterly Results
            Premium
            Market News
            Altria (NYSE:MO) Gains after Reporting Quarterly Results
            2y ago
            Altria (NYSE:MO) Gains on Q4 Results and $1B Buyback
            Premium
            Market News
            Altria (NYSE:MO) Gains on Q4 Results and $1B Buyback
            2y ago